Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Kezar Life Sciences Inc

KZR
6,36
-0,16 (-2,45%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/12/202422:45EDGAR2Form 8-K - Current report
12/11/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:06EDGAR2Form 8-K - Current report
12/11/202422:01BWKezar Life Sciences Reports Third Quarter 2024 Financial..
29/10/202422:05EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
28/10/202421:06EDGAR2Form 8-K - Current report
28/10/202413:30BWKezar Life Sciences Announces 1-for-10 Reverse Stock Split
17/10/202415:22EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
17/10/202414:47EDGAR2Form 8-K - Current report
17/10/202414:35BWKezar Board Unanimously Rejects Unsolicited Concentra..
17/10/202414:30BWKezar Life Sciences Announces Positive IDMC Safety Review of..
10/10/202414:42EDGAR2Form 8-K - Current report
10/10/202414:30BWKezar Confirms Receipt of Unsolicited, Non-Binding..
04/10/202423:05EDGAR2Form 8-K - Current report
04/10/202423:00BWKezar Life Sciences Announces Clinical Hold of Zetomipzomib..
30/9/202414:36EDGAR2Form 8-K - Current report
30/9/202414:30BWKezar Life Sciences Announces Cessation of Enrollment and..
04/9/202422:01BWKezar Life Sciences to Present at the H.C. Wainwright 26th..
13/8/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:05EDGAR2Form 8-K - Current report
13/8/202422:02BWKezar Life Sciences Reports Second Quarter 2024 Financial..
26/7/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202422:01BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
07/6/202423:59BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
04/6/202422:30EDGAR2Form 8-K - Current report
29/5/202422:01BWKezar Life Sciences to Participate in the Jefferies Global..
09/5/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:04EDGAR2Form 8-K - Current report
09/5/202422:01BWKezar Life Sciences Reports First Quarter 2024 Financial..
06/5/202422:05BWKezar Announces Inducement Grants Under NASDAQ Listing Rule..
08/4/202422:01BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
14/3/202421:01BWKezar Life Sciences Reports Fourth Quarter and Year End 2023..
08/3/202422:05BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
28/2/202422:01BWKezar Life Sciences to Participate in the TD Cowen 44th..
27/2/202400:30BWEverest Medicines and Kezar Life Sciences Receive IND..
14/2/202412:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202423:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/1/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:36EDGAR2Form 8-K - Current report
Apertura: 6,49 Min: 6,35 Max: 6,75
Chiusura: 6,52

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network